HROW
Harrow Health Inc
30.60$
+0.9%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -3.5% | 23.9% | -13.4% | -5.6% | 6.0% | -26.6% | 41.1% | -1.3% | 23.2% | 9.4% | -20.3% | -13.8% | 2.3% | |
| 9.3% | 8.4% | 9.2% | 6.5% | 6.8% | 7.2% | 10.3% | 7.7% | 6.8% | 5.6% | 12.6% | -7.9% | 3.6% | |
| 13.1% | 11.5% | 12.1% | 8.7% | 8.9% | 7.2% | 9.5% | 1.4% | 4.6% | 4.3% | 8.7% | -5.4% | 2.6% | |
| -12.9% | 23.9% | -1.6% | -14.8% | -3.4% | -52.6% | 55.6% | -20.5% | -2.4% | -13.1% | 19.8% | -12.4% | -4.8% | |
| 58.8% | 0.6% | 0.3% | 0.7% | 1.2% | 56.2% | 0.4% | 0.3% | 0.3% | 0.4% | 0.4% | 0.3% | 0.3% | |
| -58.8% | -0.6% | -0.3% | 10.4% | -1.2% | -56.2% | -0.4% | -0.5% | -0.3% | -5.3% | -41.2% | -0.8% | -8.6% | |
| -35.9% | -0.1% | -3.3% | – | -2.4% | – | – | -20.0% | – | – | – | – | – | |
| – | – | – | – | 0.0% | 44.6% | 0.0% | 0.0% | 18.8% | 0.0% | 110.9% | 0.0% | 22.7% | |
| 187.3% | 0.0% | -2.3% | 0.1% | -1.5% | 44.9% | 0.0% | -19.9% | 6.9% | -5.7% | 110.7% | -0.7% | 17.5% | |
| 125.1% | 23.3% | -16.0% | 5.0% | 3.3% | -37.9% | 40.7% | -21.6% | 29.8% | -1.5% | 49.1% | -15.3% | 11.2% | |
| -62.3% | 23.4% | -13.6% | -6.3% | 4.8% | -82.8% | 40.7% | -1.5% | 22.8% | 9.1% | -20.8% | -13.5% | 2.1% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.